The International journal on drug policy
-
Int. J. Drug Policy · Oct 2007
ReviewGlobal estimates of prevalence of HCV infection among injecting drug users.
In this paper, we review evidence of HCV prevalence among injecting drug users (IDUs) worldwide. ⋯ Taken together, data suggest high global prevalence of HCV and HIV/HCV co-infection among IDUs. We suggest exploring protective factors in sites of low HCV prevalence.
-
Int. J. Drug Policy · Oct 2007
ReviewIntegrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
New York State is home to an estimated 230,000 individuals chronically infected with hepatitis C virus (HCV) and roughly 171,500 active injection drug users (IDUs). HCV/HIV co-infection is common and models of service delivery that effectively meet IDUs' needs are required. A HCV strategic plan has stressed integration. ⋯ A comprehensive, public health approach, using multiple strategies across systems and mobilizing multiple sectors, can enhance IDUs access to HCV prevention and care. A holisitic approach with integrated services, including for HCV-HIV co-infected IDUs is needed. Leadership, collaboration and resources are essential.